Sol-Gel Technologies (SLGL) Cash & Current Investments (2016 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Cash & Current Investments came in at $10.1 million in Q1 2026, down 40.03% year-on-year from $16.9 million in Q1 2025, and down 57.76% on a QoQ basis from $24.0 million in Q4 2025.

Sol-Gel Technologies (SLGL) Cash & Current Investments (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Cash & Current Investments data on file, last reported at $10.1 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 40.03% year-over-year to $10.1 million in Q1 2026; TTM through Mar 2026 was $10.1 million, a 40.03% decrease from a year earlier, with the FY2025 full-year figure at $24.0 million, up 16.07% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $10.1 million, down from $24.0 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for SLGL reached as high as $42.2 million in Q2 2022 and fell as low as $6.7 million in Q3 2025.
  • Historically, Cash & Current Investments has averaged $21.4 million across 5 years, with a median of $20.7 million in 2025.
  • Across the five-year window, Cash & Current Investments soared 32.46% in 2023 and plunged 49.95% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $21.1 million in 2022, then surged by 32.46% to $28.0 million in 2023, then slumped by 30.31% to $19.5 million in 2024, then rose by 23.07% to $24.0 million in 2025, then tumbled by 57.76% to $10.1 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $10.1 million in Q1 2026, $24.0 million in Q4 2025, and $6.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Sol-Gel Technologies 226.64 Mn 216.50 Mn - 10.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.14 Mn
Dec 31, 2025 24.00 Mn
Sep 30, 2025 6.72 Mn
Jun 30, 2025 20.68 Mn
Mar 31, 2025 16.90 Mn
Dec 31, 2024 19.50 Mn
Sep 30, 2024 13.42 Mn
Jun 30, 2024 16.72 Mn
Mar 31, 2024 16.22 Mn
Dec 31, 2023 27.98 Mn
Sep 30, 2023 26.14 Mn
Jun 30, 2023 30.29 Mn
Mar 31, 2023 15.31 Mn
Dec 31, 2022 21.13 Mn
Sep 30, 2022 25.50 Mn
Jun 30, 2022 42.24 Mn
Mar 31, 2022 30.25 Mn
Dec 31, 2021 21.79 Mn
Sep 30, 2021 43.35 Mn
Jun 30, 2021 33.20 Mn